Born in Winnipeg, Manitoba, Canada, she moved to Beaumont at the age of 20 to pursue a career in nursing and has since developed an exceptional career in healthcare. Gay-Lynne has more than 30 years of experience in oncology services and an outstanding reputation among local and national cancer organizations. The Baptist Cancer Network (BCN) is comprised of three campuses – the BCN Julie and Ben Rogers campus (Beaumont), BCN Altus Cancer Center (Beaumont) and the BCN Cancer Center of Southeast Texas (Port Arthur). Gay-Lynne Jones is the Regional Director of the Baptist Cancer Network. She loves nature and traveling to the beach or mountains to appreciate the beauty of life. She enjoys participating in church functions, reading, shopping, and decorating in her spare time. Michele also loves to spend time with her husband and 5 children. Michele helps guide oncology patients through their cancer journey by providing an environment of care that is safe and efficient, while exhibiting a commitment to caring for the patients in our facilities. She has educated youth on tobacco awareness with Ben’s Kids summer youth camp 2 years in a row, among other distinctions in the field. She has attended and worked many health fairs in the community in effort to promote Oncology screenings and patient awareness of cancer prevention. She maintains her Chemotherapy/Biotherapy provider card which enables her to administer chemotherapy and biotherapy drugs. Michele has been an Oncology Certified Nurse since 1999 and has used her knowledge to work in many areas of Oncology including chemotherapy administration, patient and community education, clinic nursing and quality nursing. She also serves on the Cancer Committee as the Quality Coordinator, where she and the team conduct studies to improve the quality of care provided to BCN patients. Together with the clinical management team, Michele manages an educated, dedicated and compassionate staff who care for cancer patients and patients with blood disorders. To learn more about these studies, you can find the protocols at or you may contact Research Coordinator Telice Terro at 40 or Chaisson, RN, OCN is the Clinical Manager at the Baptist Cancer Network, where she leads, develops and coordinates clinical staff. ICARE-Registry-Inherited CAncer REgistry (ICARE) Initiative: Registry opportunity through Vanderbilt-Ingram Cancer Center for individuals with a personal and/or family history of cancer. Women enrolled in this study will receive either text message motivation, counselor motivation, text and counselor motivation, or standard of care. The medicines are endocrine therapies and include Tamoxifen or Arimidex. Patients enrolled in study will receive either olanzapine or megestrol for appetite stimulation and follow-up on treatment for 4 weeks.Ī191901 (GET SET)-Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions (GET SET stands for Guiding Endocrine Therapy Success through Empowerment and Technology): Research opportunity for women who take medicine to help keep breast cancer from coming back. Women will be follow-up while on and after treatment to assess neuropathy.Ī222004-A Randomized Phase III Trial Of Olanzapine Versus Megestrol Acetate For Cancer-Associated Anorexia: Research opportunity for patients with advanced cancer with anorexia related to their diagnosis. Women enrolled in study will receive standard of care chemotherapy, as planned by oncologist. Current trials open at Baptist Cancer Network:ĮAZ171-Prospective Validation Trial of Taxane Therapy (Docetaxel or Weekly Paclitaxel) and Risk of Chemotherapy-Induced Peripheral Neuropathy in African American Women: Research opportunity for African American Women receiving standard of care chemotherapy with a Taxane (Taxol or Taxotere).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |